Income Statement (TTM)
Sutro Biopharma, Inc. Income Statement shows changes in income and expenses over a period of time. Income Statement data includes Sales and Revenue, Gross Profit, Research and Development (R&D), Selling, General and Administrative Expense (SG&A), Operating Income, Income Tax Expense, Interest Expense, Non-Operating Income, Earnings per Share (EPS), and Shares Outstanding.
All numbers are times 1,000,000 except per share units.
|
2020 09-30 |
2020 12-31 |
2021 03-31 |
2021 06-30 |
2021 09-30 |
2021 12-31 |
2022 03-31 |
2022 06-30 |
2022 09-30 |
2022 12-31 |
2023 03-31 |
2023 06-30 |
2023 09-30 |
2023 12-31 |
2024 03-31 |
2024 06-30 |
2024 09-30 |
2024 12-31 |
2025 03-31 |
2025 06-30 |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 46 | 43 | 50 | 69 | 60 | 62 | 53 | 53 | 70 | 68 | 75 | 57 | 49 | 154 | 154 | 169 | 161 | 62 | 66 | 104 |
| Change (%) | -6.62 | 17.57 | 36.99 | -13.52 | 3.99 | -14.16 | 0.09 | 31.28 | -2.90 | 10.00 | -23.72 | -14.46 | 216.05 | 0.22 | 9.93 | -4.96 | -61.45 | 7.08 | 57.26 | |
| % of Revenue | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 |
| Cost Of Sales | 72 | 77 | 82 | 90 | 97 | 104 | 112 | 119 | 124 | 10 | 147 | 156 | 170 | 12 | -24 | 50 | 66 | 13 | 12 | -16 |
| Change (%) | 7.46 | 6.42 | 9.85 | 8.05 | 7.40 | 7.11 | 6.28 | 4.30 | -91.85 | 1,350.43 | 6.32 | 8.95 | -93.03 | -306.16 | -303.91 | 33.05 | -81.11 | -7.12 | -241.85 | |
| % of Revenue | 156.54 | 180.14 | 163.06 | 130.75 | 163.37 | 168.71 | 210.53 | 223.56 | 177.61 | 14.91 | 196.62 | 274.05 | 349.07 | 7.70 | -15.83 | 29.37 | 41.12 | 20.15 | 17.48 | -15.77 |
| Gross Operating Profit | -26 | -34 | -32 | -21 | -38 | -43 | -59 | -66 | -54 | 58 | -72 | -99 | -121 | 142 | 178 | 120 | 95 | 50 | 55 | 121 |
| Change (%) | 32.37 | -7.49 | -33.19 | 78.20 | 12.76 | 38.08 | 11.88 | -17.53 | -206.46 | -224.91 | 37.41 | 22.41 | -217.12 | 25.76 | -32.97 | -20.77 | -47.73 | 10.66 | 120.62 | |
| % of Revenue | -56.54 | -80.14 | -63.06 | -30.75 | -63.37 | -68.71 | -110.53 | -123.56 | -77.61 | 85.09 | -96.62 | -174.05 | -249.07 | 92.30 | 115.83 | 70.63 | 58.88 | 79.85 | 82.52 | 115.77 |
| SG&A | 38 | 37 | 39 | 41 | 48 | 56 | 60 | 63 | 61 | 60 | 60 | 60 | 60 | 63 | 60 | 57 | 56 | 48 | 49 | 47 |
| Change (%) | -4.08 | 6.18 | 5.36 | 15.56 | 17.66 | 7.02 | 4.33 | -3.11 | -1.72 | 0.79 | -0.24 | 1.05 | 3.45 | -4.46 | -4.40 | -1.64 | -13.83 | 1.14 | -4.14 | |
| % of Revenue | 83.90 | 86.18 | 77.83 | 59.86 | 79.99 | 90.50 | 112.84 | 117.62 | 86.81 | 87.86 | 80.51 | 105.29 | 124.38 | 40.71 | 38.81 | 33.75 | 34.93 | 78.10 | 73.76 | 44.97 |
| R&D | 127 | 169 | 222 | 169 | 169 | 240 | 235 | 240 | ||||||||||||
| Change (%) | 31.85 | -24.16 | 0.00 | 42.08 | -1.83 | 1.87 | ||||||||||||||
| % of Revenue | 187.49 | 109.67 | 144.29 | 99.55 | 104.75 | 386.09 | 353.96 | 229.28 | ||||||||||||
| OpEx | 110 | 114 | 121 | 131 | 145 | 160 | 172 | 181 | 185 | 197 | 207 | 216 | 230 | 243 | 258 | 275 | 291 | 300 | 296 | 270 |
| Change (%) | 3.44 | 6.35 | 8.40 | 10.41 | 10.77 | 7.08 | 5.60 | 1.75 | 6.59 | 5.02 | 4.41 | 6.76 | 5.52 | 6.04 | 6.91 | 5.63 | 3.26 | -1.57 | -8.70 | |
| % of Revenue | 240.44 | 266.32 | 240.89 | 190.61 | 243.36 | 259.22 | 323.37 | 341.18 | 264.42 | 290.26 | 277.13 | 379.34 | 473.45 | 158.07 | 167.27 | 162.67 | 180.79 | 484.34 | 445.20 | 258.48 |
| Operating Income | -64 | -71 | -71 | -62 | -85 | -99 | -119 | -128 | -115 | -129 | -132 | -159 | -182 | -89 | -104 | -106 | -130 | -238 | -229 | -166 |
| Change (%) | 10.60 | -0.41 | -11.90 | 36.82 | 15.49 | 20.42 | 8.07 | -10.50 | 12.36 | 2.41 | 20.30 | 14.36 | -50.85 | 16.08 | 2.42 | 22.52 | 83.36 | -3.82 | -27.80 | |
| % of Revenue | -140.44 | -166.32 | -140.89 | -90.61 | -143.36 | -159.22 | -223.37 | -241.18 | -164.42 | -190.26 | -177.13 | -279.34 | -373.45 | -58.07 | -67.27 | -62.67 | -80.79 | -384.34 | -345.20 | -158.48 |
| Interest Expense | -5 | -3 | -3 | -3 | -3 | -3 | -3 | -3 | -3 | -7 | -5 | -8 | -16 | -24 | -30 | -36 | -37 | -32 | -34 | -35 |
| Change (%) | -46.63 | -7.14 | 23.08 | -3.12 | 3.23 | -0.00 | -9.38 | 6.90 | 139.35 | -30.11 | 53.16 | 97.88 | 51.10 | 26.99 | 18.86 | 2.14 | -11.60 | 3.85 | 4.88 | |
| % of Revenue | -11.47 | -6.55 | -5.18 | -4.65 | -5.21 | -5.17 | -6.02 | -5.45 | -4.44 | -10.95 | -6.96 | -13.97 | -32.31 | -15.45 | -19.58 | -21.17 | -22.75 | -52.17 | -50.60 | -33.75 |
| Net Income | 13 | -32 | -43 | -79 | -127 | -106 | -114 | -134 | -123 | -119 | -130 | -143 | -172 | -107 | -115 | -124 | -124 | -227 | -245 | -209 |
| Change (%) | -354.44 | 33.50 | 83.99 | 60.88 | -16.87 | 8.29 | 17.38 | -8.51 | -2.88 | 9.18 | 9.61 | 20.89 | -38.07 | 7.64 | 8.26 | -0.40 | 83.51 | 7.81 | -14.89 | |
| % of Revenue | 27.60 | -75.20 | -85.39 | -114.69 | -213.36 | -170.55 | -215.16 | -252.33 | -175.85 | -175.89 | -174.58 | -250.87 | -354.53 | -69.47 | -74.62 | -73.48 | -77.01 | -366.62 | -369.11 | -199.76 |
Source: Capital IQ
